Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Sockel

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Bone Marrow Transplantation|November 5, 2024
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial dataMatthias Stelljes, Katja Sockel, Matthias Floeth, et al.
Blood Advances|January 10, 2022
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatmentRaphael Teipel, Frank Kroschinsky, Michael Kramer, et al.
Hemasphere|April 16, 2026
Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone lossManja Wobus, Heike Weidner, Rebekka Wehner, et al.
Transplantation and Cellular Therapy|August 26, 2023
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter StudyAlexandros Rampotas, Katja Sockel, Fotios Panitsas, et al.
Experimental Hematology|January 16, 2022
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantationAbed A Sarraf, Johannes Schetelig, Henning Baldauf, et al.
Hemasphere|February 2, 2026
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survivalAida Santaolalla, Uta Oelschlaegel, Susann Winter, et al.
Annals of Hematology|July 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patientsStefanie Jilg, Juliana Schwaab, Katja Sockel, et al.
BMC Cancer|February 23, 2022
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smearsJan-Niklas Eckardt, Tim Schmittmann, Sebastian Riechert, et al.
British Journal of Haematology|November 9, 2018
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patientsRobin Boutault, Pierre Peterlin, Marouane Boubaya, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJan M Middeke, Frederike Kollinger, Henning Baldauf, et al.
Bone Marrow Transplantation|November 5, 2024
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial dataMatthias Stelljes, Katja Sockel, Matthias Floeth, et al.
Blood Advances|January 10, 2022
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatmentRaphael Teipel, Frank Kroschinsky, Michael Kramer, et al.
Hemasphere|April 16, 2026
Preclinical efficacy of tasquinimod in myelodysplastic neoplasms: Restoring erythropoiesis and mitigating bone lossManja Wobus, Heike Weidner, Rebekka Wehner, et al.
Transplantation and Cellular Therapy|August 26, 2023
Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter StudyAlexandros Rampotas, Katja Sockel, Fotios Panitsas, et al.
Experimental Hematology|January 16, 2022
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantationAbed A Sarraf, Johannes Schetelig, Henning Baldauf, et al.
Hemasphere|February 2, 2026
Prognostic value of flow cytometry in myelodysplastic neoplasms (MDS): Composition of a FCM-prognostic score (FCM-PS) for overall survivalAida Santaolalla, Uta Oelschlaegel, Susann Winter, et al.
Annals of Hematology|July 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patientsStefanie Jilg, Juliana Schwaab, Katja Sockel, et al.
BMC Cancer|February 23, 2022
Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smearsJan-Niklas Eckardt, Tim Schmittmann, Sebastian Riechert, et al.
British Journal of Haematology|November 9, 2018
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patientsRobin Boutault, Pierre Peterlin, Marouane Boubaya, et al.
Pageof 10